Optum Epidemiology is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Optum Epidemiology has participated in 2 clinical trials.
Therapeutic areas: Type 2 Diabetes.
Sponsors: AstraZeneca.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Optum Epidemiology has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Optum Epidemiology has 2 clinical trials on record. Their work covers Type 2 Diabetes.
Optum Epidemiology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.